A distinct molecular profile associated with mucinous epithelial ovarian cancer.
about
Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survivalEmerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachGene expression profiling in sinonasal adenocarcinoma.Mucins in ovarian cancer diagnosis and therapyCathepsins B, L and cystatin C in cyst fluid of ovarian tumors.Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients.Meta-analysis of gene expression profiles associated with histological classification and survival in 829 ovarian cancer samples.Measurement of phospholipids may improve diagnostic accuracy in ovarian cancerMucinous tumors of the ovary: current thoughts on diagnosis and managementUnmasking the complexities of mucinous ovarian carcinoma.Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan arrayMicroenvironment and pathogenesis of epithelial ovarian cancerGenetic variations of MUC17 are associated with endometriosis development and related infertility.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Genome-wide significant risk associations for mucinous ovarian carcinomaLow meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries.Expression patterns suggest that despite considerable functional redundancy, galectin-4 and -6 play distinct roles in normal and damaged mouse digestive tractOvarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype.Genomic analysis of epithelial ovarian cancer.Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.Future directions in the management of epithelial ovarian cancer.Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients.Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer.Ovarian cancer: genomic analysis.Gene expression analysis in ovarian cancer - faults and hints from DNA microarray study.Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features.Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.Galectins as cancer biomarkers.PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature.Human Three-Dimensional Endometrial Epithelial Cell Model To Study Host Interactions with Vaginal Bacteria and Neisseria gonorrhoeae.Proteogenomic studies in epithelial ovarian cancer: established knowledge and future needs.Promoter SNPs rs116896264 and rs73933062 form a distinct haplotype and are associated with galectin-4 overexpression in colorectal cancer.Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.New insights into ovarian cancer pathology.Genetic changes correlate with histopathology in a benign, borderline and malignant mucinous ovarian tumour.Recent Insights into Mucinous Ovarian Carcinoma.
P2860
Q24655625-24A8AB69-233C-49BE-AE88-48567CE5A8F8Q26849477-F346F35F-4722-45B5-8CE1-23D325E3517BQ33515693-A5CF2667-75EE-4D11-A408-C4A178713F39Q33583166-0DF88544-025C-4BD2-90C1-7033FD1A5ECBQ33739577-5218040A-B71D-4828-8F1D-E3B507B59081Q34171495-55C5A6C7-79E7-4035-8874-EE7E4AF330B5Q34209814-BF5A08D2-39F3-4DBF-A604-1D598B8084ECQ34451931-34FEAAB6-2ACC-4F5C-92E9-EB51FBFFE392Q34667838-B46DFCC6-F37B-4E41-B478-4D7B3A574C14Q34695404-9055DDE2-9C24-4AA3-A366-A90F1E142C85Q35109145-053E4E94-AF9A-4B3A-95BE-2893B63452CAQ35419057-42DE79DE-24D7-456D-9F17-5F95A1C903A6Q35749217-64169423-D9FB-4F63-91C9-9E6777773ABEQ35837949-6D7B3FBF-AEA9-4092-8107-DC9B9281E625Q35904590-BE7BCE7A-7554-4CE3-B6BC-5BEEF2EF70EDQ35954378-5623D293-E8CD-4A82-9942-CF652475484BQ36796308-44F13519-0FF7-4F69-B129-72C417E35B1CQ37033992-7F94471D-B0AF-435C-BF54-BBD705251400Q37144104-45333829-7828-4424-85BA-5AD6F4AA4994Q37155520-024B4C2D-BAD5-492A-B82D-0364994D5C30Q37179400-D15B48D0-8486-4A20-AE0B-73EC3DE51487Q37249734-277280C5-2115-48A5-9CA1-274E4A610897Q37326840-303776EF-2E83-4AB9-996D-E16F813C2643Q37332480-991B1371-9F16-41A7-A05C-A82C23A0297AQ37522638-9F7EAFB3-84F3-4327-9AA8-5C2E05DF6496Q37982940-2ED1A1A8-3234-4515-B78A-006455178A4FQ38019412-94820D83-C6D0-4101-89AC-1F2EE65CA817Q38105320-04B6D0D5-665D-4C4D-90DE-433B77F7B84AQ38707402-BB3A01DB-D883-4D41-B167-8419BC17A8ABQ38722955-7A04B5D1-CCD9-4960-B70A-5B7FBD49EC2FQ39872610-05F6E784-BCA2-4368-BE14-06DE55E75BD0Q40197366-73FD80A7-CD81-4060-8DC5-10223824B663Q49937490-47D58E58-A445-4CCD-B6BA-BF9834DE0127Q51021273-7FE3728A-76E5-4E65-8B93-F89A90EBEE18Q53143668-C28E8A60-B468-4F59-A4CF-2070F6D780E3Q53320644-606C27EF-2C28-4A26-9A0C-BF0305CB39ACQ55609057-F036B53F-D9B3-4510-9A37-5538A01A261A
P2860
A distinct molecular profile associated with mucinous epithelial ovarian cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A distinct molecular profile associated with mucinous epithelial ovarian cancer.
@ast
A distinct molecular profile associated with mucinous epithelial ovarian cancer.
@en
type
label
A distinct molecular profile associated with mucinous epithelial ovarian cancer.
@ast
A distinct molecular profile associated with mucinous epithelial ovarian cancer.
@en
prefLabel
A distinct molecular profile associated with mucinous epithelial ovarian cancer.
@ast
A distinct molecular profile associated with mucinous epithelial ovarian cancer.
@en
P2093
P2860
P356
P1476
A distinct molecular profile associated with mucinous epithelial ovarian cancer
@en
P2093
J P Scurry
M Gardiner-Garden
N F Hacker
P M O'Brien
P Vanden Bergh
R L Sutherland
S Baron-Hay
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603003
P407
P577
2006-03-01T00:00:00Z